Gilead Sciences Inc (GILD)
65.27
-1.81
(-2.70%)
USD |
NASDAQ |
Apr 25, 16:00
65.15
-0.12
(-0.18%)
After-Hours: 20:00
Gilead Sciences Free Cash Flow: 7.421B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.421B |
| September 30, 2023 | 7.853B |
| June 30, 2023 | 8.926B |
| March 31, 2023 | 8.386B |
| December 31, 2022 | 8.344B |
| September 30, 2022 | 9.007B |
| June 30, 2022 | 9.415B |
| March 31, 2022 | 9.953B |
| December 31, 2021 | 10.80B |
| September 30, 2021 | 9.491B |
| June 30, 2021 | 8.472B |
| March 31, 2021 | 8.698B |
| December 31, 2020 | 7.518B |
| September 30, 2020 | 8.16B |
| June 30, 2020 | 8.51B |
| March 31, 2020 | 8.244B |
| December 31, 2019 | 8.319B |
| September 30, 2019 | 8.039B |
| June 30, 2019 | 7.639B |
| March 31, 2019 | 6.758B |
| December 31, 2018 | 7.476B |
| September 30, 2018 | 7.912B |
| June 30, 2018 | 8.432B |
| March 31, 2018 | 10.56B |
| December 31, 2017 | 11.31B |
| Date | Value |
|---|---|
| September 30, 2017 | 12.14B |
| June 30, 2017 | 13.78B |
| March 31, 2017 | 15.15B |
| December 31, 2016 | 16.30B |
| September 30, 2016 | 18.56B |
| June 30, 2016 | 18.17B |
| March 31, 2016 | 18.88B |
| December 31, 2015 | 20.50B |
| September 30, 2015 | 17.73B |
| June 30, 2015 | 17.83B |
| March 31, 2015 | 16.43B |
| December 31, 2014 | 12.26B |
| September 30, 2014 | 10.07B |
| June 30, 2014 | 6.872B |
| March 31, 2014 | 3.686B |
| December 31, 2013 | 2.915B |
| September 30, 2013 | 2.693B |
| June 30, 2013 | 2.656B |
| March 31, 2013 | 3.001B |
| December 31, 2012 | 2.798B |
| September 30, 2012 | 3.314B |
| June 30, 2012 | 3.468B |
| March 31, 2012 | 3.131B |
| December 31, 2011 | 3.507B |
| September 30, 2011 | 3.257B |
Free Cash Flow Range, Past 5 Years
7.421B
Minimum
Dec 2023
10.80B
Maximum
Dec 2021
8.589B
Average
8.386B
Median
Mar 2023
Free Cash Flow Benchmarks
| Amgen Inc | 7.359B |
| Johnson & Johnson | 17.78B |
| Eli Lilly and Co | -3.152B |
| Pfizer Inc | 4.793B |
| CymaBay Therapeutics Inc (DELISTED) | -72.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.169B |
| Cash from Investing (Quarterly) | -727.00M |
| Cash from Financing (Quarterly) | -1.099B |
| Free Cash Flow Per Share (Quarterly) | 1.557 |
| Free Cash Flow to Equity (Quarterly) | 1.949B |
| Free Cash Flow to Firm (Quarterly) | 2.170B |
| Free Cash Flow Yield | 9.04% |